North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations

被引:1
作者
Alhusayen, Raed [1 ,2 ]
Dienes, Serena [3 ]
Lam, Megan [2 ]
Alavi, Afsaneh [4 ]
Alikhan, Ali [5 ]
Aleshin, Maria [6 ]
Bahashwan, Emad [7 ]
Daveluy, Steve [8 ]
Goldfarb, Noah [9 ]
Garg, Amit [10 ]
Gulliver, Wayne [11 ]
Jaleel, Tarannum [12 ]
Kimball, Alexa B. [13 ,14 ]
Kirchhof, Mark G. [15 ,16 ]
Kirby, Joslyn [17 ,18 ]
Lenczowski, Joi [19 ]
Lev-Tov, Hadar [20 ]
Lowes, Michelle A. [21 ]
Lara-Corrales, Irene [22 ]
Micheletti, Robert [23 ]
Okun, Martin [24 ]
Orenstein, Lauren [25 ]
Poelman, Susan [26 ,27 ]
Piguet, Vincent [28 ,29 ]
Porter, Martina [30 ,31 ]
Resnik, Barry [20 ,32 ]
Sibbald, Cathryn [2 ,22 ]
Shi, Vivian [33 ]
Sayed, Christopher [34 ]
Wong, Se Mang [35 ]
Zaenglein, Andrea [36 ]
Veillette, Helene [37 ]
Hsiao, Jennifer L. [38 ]
Naik, Haley B. [39 ]
机构
[1] Sunnybrook Res Inst, Toronto, ON, Canada
[2] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada
[3] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[4] Mayo Clin, Dept Dermatol, Rochester, MN USA
[5] Sutter Med Fdn, Sacramento, CA USA
[6] Stanford Univ, Sch Med, Dept Dermatol, Stanford, CA USA
[7] Bisha Univ, Fac Med, Dermatol Div, Bisha, Saudi Arabia
[8] Wayne State Univ, Sch Med, Sch Med, Detroit, MI USA
[9] Univ Minnesota, Dept Dermatol, Minneapolis, MN USA
[10] Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Dermatol, New Hyde Pk, NY USA
[11] Mem Univ Newfoundland, Fac Nursing, St John, NF, Canada
[12] Duke Univ, Sch Med, Dept Dermatol, Durham, NC USA
[13] Beth Israel Deaconess Med Ctr, Dept Dermatol, Clin Lab Epidemiol & Appl Res Skin CLEARS, Boston, MA USA
[14] Harvard Med Sch, Dept Dermatol, Boston, MA USA
[15] Univ Ottawa, Dept Med, Div Dermatol, Ottawa, ON, Canada
[16] Ottawa Hosp, Dept Med, Div Dermatol, Ottawa, ON, Canada
[17] Incyte Corp, Wilmington, DE USA
[18] Penn State Hlth, Dept Dermatol, Hershey, PA USA
[19] Richmond VAMC, Richmond, VA USA
[20] Univ Miami, Miller Sch Med, Dr Phillip Frost Dept Dermatol & Cutaneous Surg, Miami, FL USA
[21] Rockefeller Univ, Lab Invest Dermatol, New York, NY USA
[22] Hosp Sick Children, Dept Pediat, Div Neurol, Toronto, ON, Canada
[23] Univ Med, Perelman Sch Med, Philadelphia, PA USA
[24] Ft HealthCare, Ft Atkinson, WI USA
[25] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA USA
[26] Univ Calgary, Div Dermatol, Calgary, AB, Canada
[27] Beacon Dermatol, Calgary, AB, Canada
[28] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada
[29] Womens Coll Hosp, Toronto, ON, Canada
[30] Beth Israel Deaconess Med Ctr, Dept Dermatol, Boston, MA USA
[31] Harvard Med Sch, Boston, MA USA
[32] Resnik Skin Inst, Miami, FL USA
[33] Univ Washington, Dept Dermatol, Seattle, WA USA
[34] Univ North Carolina Chapel Hill, Dept Dermatol, Chapel Hill, NC USA
[35] Univ British Columbia, Fac Management, Kelowna, BC, Canada
[36] Penn State Childrens Hosp, Hershey, PA USA
[37] CHU Quebec Univ Laval, Dept Med, Div Dermatol, Quebec City, PQ, Canada
[38] Univ Southern Calif, Dept Dermatol, Los Angeles, CA USA
[39] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA
关键词
antiandrogens; antibiotics; biologics; breastfeeding; comorbidity; guidelines; hepatitis B; hepatitis C; hidradenitis suppurativa; HIV; immunomodulators; immunosuppressive; malignancy; man-; agement; North America; pediatric; pregnancy; safety; therapy; tuberculosis; INFLAMMATORY-BOWEL-DISEASE; LATENT TUBERCULOSIS INFECTION; BREAST-CANCER RECURRENCE; CHRONIC HEPATITIS-C; GESTATIONAL DIABETES-MELLITUS; SPONTANEOUS BACTERIAL PERITONITIS; CARDIOVASCULAR BIRTH-DEFECTS; RISK NEUTROPENIC PATIENTS; PLACEBO-CONTROLLED TRIAL; SQUAMOUS-CELL CARCINOMA;
D O I
10.1016/j.jaad.2024.11.071
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Hidradenitis suppurativa (HS) affects different patient populations that require unique considerations in their management. However, no HS guidelines for these populations exist. Objective: To provide evidence-based consensus recommendations for patients with HS in 7 special patient populations: (i) pregnancy, (ii) breastfeeding, (iii) pediatrics, (iv) malignancy, (v) tuberculosis infection, (vi) hepatitis B or C infection, and (vii) HIV disease. Methods: Recommendations were developed using the Grading of Recommendations Assessment, Development, and Evaluation system to ascertain level of evidence and selected through a modified Delphi consensus process. Results: One hundred eighteen expert consensus statements are provided for the management of patients with HS across these 7 special patient populations.
引用
收藏
页码:825 / 852
页数:28
相关论文
共 319 条
[1]   The potential hepatoprotective effect of metformin in hepatitis C virus-infected adolescent patients with beta thalassemia major: Randomised clinical trial [J].
Abdel Monem, Mona S. ;
Farid, Samar F. ;
Abbassi, Maggie M. ;
Youssry, Ilham ;
Andraues, Nevine G. ;
Hassany, Mohamed ;
Selim, Yasmeen M. M. ;
El-Sayed, Manal H. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (06)
[2]   Infliximab in Pediatric Rheumatology Patients: A Retrospective Analysis of Infusion Reactions and Severe Adverse Events During 2246 Infusions over 12 Years [J].
Aeschlimann, Florence A. ;
Hofer, Kevin D. ;
Schneider, Elvira Cannizzaro ;
Schroeder, Silke ;
Lauener, Roger ;
Saurenmann, Rotraud K. .
JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) :1409-1415
[3]   Risk of Hepatitis B Virus (HBV) Reactivation in Patients with Immune-Mediated Inflammatory Diseases Receiving Biologics: Focus on the Timing of Biologics after Anti-HBV Treatment [J].
Ahn, Soo Min ;
Choi, Jonggi ;
Yee, Byong Duk ;
Yang, Suk-Kyun ;
Oh, Ji Seon ;
Kim, Yong-Gil ;
Lee, Chang-Keun ;
Yoo, Bin ;
Park, Sang Hyoung ;
Hong, Seokchan .
GUT AND LIVER, 2021, :567-574
[4]   Pro-inflammatory and anti-inflammatory cytokine profiles in fetal growth restriction [J].
Al-Azemi, M. ;
Raghupathy, R. ;
Azizieh, F. .
CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2017, 44 (01) :98-103
[5]   A Study of Optimal Screening for Latent Tuberculosis in Patients with Inflammatory Bowel Disease [J].
Al-Taweel, Talal ;
Strohl, Matthew ;
Pai, Madhukar ;
Martel, Myriam ;
Bessissow, Talat ;
Bitton, Alain ;
Seidman, Ernest ;
Afif, Waqqas .
DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (10) :2695-2702
[6]  
Alavi A, 2023, J AM ACAD DERMATOL, V89, pAB89
[7]   Janus kinase 1 inhibitor INCB054707 for patients with moderate-to-severe hidradenitis suppurativa: results from two phase II studies [J].
Alavi, Afsaneh ;
Hamzavi, Iltefat ;
Brown, Kurt ;
Santos, Leandro L. ;
Zhu, Zhaoyin ;
Liu, Huiqing ;
Howell, Michael D. ;
Kirby, Joslyn S. .
BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (05) :803-813
[8]   Local wound care and topical management of hidradenitis suppurativa [J].
Alavi, Afsaneh ;
Kirsner, Robert S. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (05) :S55-S61
[9]   North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part II: Topical, intralesional, and systemic medical management [J].
Alikhan, Ali ;
Sayed, Christopher ;
Alavi, Afsaneh ;
Alhusayen, Raed ;
Brassard, Alain ;
Burkhart, Craig ;
Crowell, Karen ;
Eisen, Daniel B. ;
Gottlieb, Alice B. ;
Hamzavi, Iltefat ;
Hazen, Paul G. ;
Jaleel, Tara ;
Kimball, Alexa B. ;
Kirby, Joslyn ;
Lowes, Michelle A. ;
Micheletti, Robert ;
Miller, Angela ;
Naik, Haley B. ;
Orgill, Dennis ;
Poulin, Yves .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (01) :91-101
[10]   Human Exposure to Triclosan via Toothpaste does not change CYP3A4 Activity or Plasma Concentrations of Thyroid Hormones [J].
Allmyr, Mats ;
Panagiotidis, Georgios ;
Sparve, Erik ;
Diczfalusy, Ulf ;
Sandborgh-Englund, Gunilla .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 (05) :339-344